The influenza A virus, human metapneumovirus (hMPV) and respiratory syncytial virus (RSV) were identified as significant ...

Clover Biopharmaceuticals announced positive Phase 2 clinical trial results in Australia for its combination vaccine ...

Get hmpv virus latest news, Article video and Photos on hmpv virus Explore latest health updates, news, information from TheHealthSite.com ...

The biotech says the mid-stage results for both of its combination respiratory vaccines support their continued development.

ENA is one of six infectious disease biotech companies sharing in $10.48m from the MRFF-backed Biointelect Venturer program.

ICMR reports H1N1 dominates Influenza A cases in India; no urgent vaccination needed, consult doctors if at risk.

But SARS-CoV-2 isn’t the only virus that can have lingering aftereffects. Other respiratory viral infections (RVIs), which ...

Schools have been asked to follow a “Healthy School - Healthy Community” approach. This includes encouraging students to cover their nose and mouth while coughing or sneezing, dispose of used tissues ...

ICMR Director General Dr. Rajiv Bahl clarified that the current H1N1 surge in India represents seasonal flu rather than a new strain. Nationwide surveillance across 73 labs shows Influenza A and B cir ...

The National Health and Research Council defines Human metapneumovirus (HMPV) as “a respiratory virus that causes a mild infection similar to a common cold or respiratory syncytial virus infection.” ...

Clover Biopharmaceuticals announced positive Phase 2 data for its combination respiratory vaccine candidates SCB-1022 (RSV + hMPV) and SCB-1033 (RSV ...

No autopsy was conducted, but the series of events convinced his parents that antimicrobial resistance – or AMR – had played ...